EN
HI
Concord Drugs Share Price
CONCORD
711.95 (-2.67%)
Last updated on 13 Nov, 2026 | 16:01 IST
Free Demat with Zero AMC*
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC
Summary
As of 16 Nov, 2026, Concord Drugs stock price is ₹71. During the trading session, the stock has moved between an intraday low of ₹71.00 and an intraday high of ₹73.50. Over the last 52 weeks, Concord Drugs has traded between ₹59.99 and ₹91.79.
The stock has recorded a trading volume of 4,218 shares,. Its Average Traded Price (ATP) is ₹71.61, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 15 @ ₹71.00.
Concord Drugs has an upper circuit limit of ₹86.01 and a lower circuit limit of ₹57.35. The total value traded stands at ₹3.02 L, and the delivery percentage for the day is 0%.
The stock is currently traded with a market lot size of 1. Concord Drugs also offers a dividend yield of 0%.
Concord Drugs Share Price Chart
Concord Drugs Share Key Metrics
Volume
4218.00
Market Cap
94.44 CR
LTQ@LTP
15@71.00
ATP
71.61
Var Margin
25 %
Circuit Range
57.35-86.01
Delivery %
0 %
Value
3.02 L
ASM/GSM
No
Market Lot
1
Concord Drugs Resistance and Support
Pivot 72.98
Resistance
First Resistance
74.42
Second Resistance
75.89
Third Resistance
77.33
Support
First Support
71.51
Second Support
70.07
Third Support
68.6
Concord Drugs Shareholding Pattern
View More- 2016-17
- 2018-19
- 2019-20
- 2020-21
- 2021-22
- 2022-23
- 2023-24
- 2024-25
- 2025-26
- 2026-27
Total Promoters
Segment
Percent
Total Promoters
45.08%
Mutual Fund
0%
Insurance
0%
Foreign Institutional Investors
0%
Domestic Institutional Investors
0%
Retail
54.92%
Others
0%
Total Promoters
MAR '26
54.39%
JUN '26
45.08%
SEP '26
45.08%
Concord Drugs Corporate Actions
| Date | Agenda |
|---|---|
| 2026-11-12 | Quarterly Results |
| 2026-08-10 | Quarterly Results |
| 2026-05-27 | Audited Results |
| 2026-02-14 | Quarterly Results |
| 2025-11-13 | Quarterly Results |
| 2025-08-08 | Quarterly Results |
| 2025-07-03 | Preferential issue of shares |
| 2025-06-27 | Preferential Issue of shares & Others |
| 2025-05-23 | Audited Results |
| 2025-03-17 | Preferential Issue of shares & Others |
| 2025-03-13 | Preferential Issue of shares & Others |
| 2025-01-11 | Quarterly Results |
| 2024-11-13 | Quarterly Results |
| 2024-08-09 | Quarterly Results |
Concord Drugs News
Concord Drugs Ltd - 538965 - Board Meeting Intimation for Results For Quarter Ending 30 Sep 2026
Concord Drugs board will meet on 12 Nov 2026 for financial results. The meeting will address the financials for the quarter ended 30 Sep 2026.
Nov 05 2026 18:19:57
Concord Drugs Management
| Name | Position |
|---|---|
| S Nagi Reddy | Chairman & Managing Director |
| S Koni Reddy | Whole Time Director & Chief Financial Officer |
Concord Drugs Similar Stocks
Mercury Laboratories Ltd.
777.70
27.30 (3.64%)
Bharat Immunologicals & Biologicals Corporation Ltd.
9.00
-0.02 (0.22%)
Pharmaids Pharmaceuticals Ltd.
28.50
-1.34 (4.49%)
Everest Organics Ltd.
252.00
10.75 (4.46%)
Cian Healthcare Ltd.
39.97
0.78 (1.99%)
Godavari Drugs Ltd.
122.00
4.55 (3.87%)
Kretto Syscon Ltd.
0.40
-0.01 (2.44%)
Vasundhara Rasayans Ltd.
124.45
0.55 (0.44%)
Concord Drugs FAQs
The Buying Price of Concord Drugs share is 71 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Concord Drugs stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Concord Drugs, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Concord Drugs shares is 31.95. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Concord Drugs shares is 1.9. Useful to assess the stock's value relative to its book value.
To assess Concord Drugs’s valuation compare Sector P/E, P/B which are 41.18 & 2.49 with sector averages, along with growth rates and financial metrics.
The Market Cap of Concord Drugs is 94.44 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Concord Drugs share price is 91.79 & 59.99. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Concord Drugs belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year
Auto Square Off Charges
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools

Open Your Free
Demat Account Now!
AMC For First Year
Account Opening Fee
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools
Invest in CONCORD
Account Opening Fee AMC for 1st Year Auto Square Off Charges Call & Trade
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC